Our Leadership
Mr. Richard Y. Lee, Ph.D.
Chairman, President and CEO
In 1993, Dr. Li Ya founded Amsino Medical Group in California, USA, and currently serves as the Group's Chairman and Chief Executive Officer.
Richard graduated from Peking University with a bachelor's degree in Economics in 1985. In the same year, he pursued further studies in the United States. Under the supervision of Professor Vernon Smith, the recipient of the 2002 Nobel Memorial Prize in Economic Sciences, he earned his Doctor of Economics degree from the University of Arizona in 1992. Prior to establishing Amsino Medical Group, Richard worked as an Assistant Professor of Economics at Gettysburg College in Pennsylvania, USA.
Richard has over 30 years of experience in the global medical device industry. His areas of expertise include general corporate management, strategic planning and execution, corporate development, mergers and acquisitions, research and development, global manufacturing, global strategic partnership, quality management systems, regulatory affairs, global sales and marketing, public relations and governmental affairs.
Under his leadership, Amsino has grown from a start-up to a global medical device company dedicated to advancing healthcare worldwide. The company operates multiple FDA registered R&D, manufacturing and distribution facilities strategically located in the US and in Asia, Amsino products are distributed in North America and in more than 100 other countries in LATAM, EMEA, and APAC.
As an Honorary Chairman of the China CEO Association, Richard is recognized as one of the most influential Chinese-American business leaders. He is also a Founder and Director of the United Beijing Association of America, Chairman of the Board of Directors of the Peking University Alumni Association, and a Director of the International Foundation for Experimental Economics in the United States. For 15 consecutive years, he has been a sponsor of Direct Relief International, supporting charitable development programs in numerous developing countries.
Mr. Peter Sun
Chief Financial Officer
Peter joined Amsino in January 2008 as the Chief Financial Officer based in Shanghai China. He received his MBA in Finance from the State University of New York at Albany.
Peter started his career in banking industry with U.S. Bancorp and later as project manager with Hewlett-Packard Company.
Peter also spent 5 years with Avanex Corporation (NASDAQ: AVNX), a Tier 1 developer and manufacturer of optical components, modules and sub-systems based in CA, as the Director of Finance and assisted the Company’s successful IPO on NASDAQ in 2001.
Prior to joining Amsino, Peter spent 4 years with Arasor International Limited (ASX: ARR), an advanced developer and manufacturer of optical laser modules based in CA, as the CFO and assisted the Company’s successful IPO on Australian Stock Exchange (ASX) in 2006.
Mr. Frank Ling
Chief Operating Officer
Frank responsibles for managing Amsino manufacturing facilities in China and Canada (MedXL Inc.), as well as the Group’s Supply Chain, Global Strategic Sourcing and Operation Center. He joined Amsino in July 2012 as General Manager of Amsino Medical (Shanghai) Co., Ltd. From November 2017 to February 2019, he held the position of Vice President of Operations, Asia Pacific. He was promoted to Senior Vice President of Operations, Asia Pacific in March 2019, and further elevated to Chief Operating Officer (COO) in June 2023.
Frank received his Bachelor’s degree in Material Science from Shanghai Jiao Tong University in 1988.
Prior to joining Amsino, Frank took different management responsibilities in several multinational corporations, mainly focusing on manufacturing operations and technological development, with broad business backgrounds in medical device, machinery manufacturing and semiconductor industries.
Ms. Sherry Wang
Chief Administrative Officer
Sherry Wang serves as Chief Administrative Officer at Amsino, where she provides strategic leadership across key corporate functions, including Human Resources, Corporate Communications, and Executive Administration. As a member of the executive leadership team, she works closely with senior management to align business strategy, strengthen organizational effectiveness, and drive operational excellence across the company. In her current role, Sherry also partners with Amsino's leadership teams across North America, Europe, and Asia to support organizational growth, operational integration, and enterprise-wide strategic initiatives.
Since rejoining Amsino in 2018 as Global Marketing Manager and Executive Assistant to the CEO, Sherry has held positions of increasing responsibility, including Director of Corporate Communications and Vice President of Operations, before being appointed Chief Administrative Officer in 2024. Throughout her tenure, she has led numerous cross-functional initiatives supporting business growth, organizational transformation, operational integration, talent development, and strategic planning. She also played a key leadership role in Amsino's COVID-19 product expansion, successfully coordinating cross-functional teams and global supplier partnerships to support critical healthcare needs during the pandemic.
Prior to her executive leadership roles, Sherry built a strong operational foundation through progressive experience in finance, logistics, warehousing, procurement, and supply chain management. This broad business background enables her to bridge strategy with execution, drive cross-functional collaboration, and deliver practical business solutions that support Amsino's long-term growth and operational excellence.
Sherry holds a Bachelor of Arts degree in Business Economics with an emphasis in Accounting from the University of California, Los Angeles (UCLA).
Mr. Jeff Reid
President, North America
As a seasoned executive in healthcare strategy, leadership, and business development, Jeff has a strong track record of driving exceptional financial results in dynamic, data-driven environments. Throughout his career, he has successfully delivered growth and innovation across various healthcare sectors by implementing enterprise-wide strategies, optimizing market positioning, and leading high-performing teams.
He specializes in identifying market opportunities, building strategic partnerships with health systems and key distributors, and aligning teams to achieve business growth objectives, all aimed at maximizing profitability. His passions lie in fostering innovation, collaboration, and sustainable growth within the healthcare industry.
Previously, Jeff held senior leadership roles at Cardinal Health and Smiths Medical, where he led transformation initiatives focused on talent development, sales process optimization, and driving consistent success across national regions.
Jeff brings a comprehensive understanding of the healthcare landscape, coupled with a results-driven approach to strategic initiatives and organizational leadership.
He holds a Bachelor of Science in Management with a Minor in Marketing from Oklahoma State University.
Mr. Derek Tang
President, International Sales & Global Marketing
Derek has joined AMSINO as President, International Sales & Global Marketing, effective January 4, 2026. He leads all sales teams across APAC, China, EMEA and LATAM business units, and is responsible for developing and executing our global marketing strategy.
Derek holds a Bachelor of Clinical Medicine from Fudan University and an Executive MBA from the National University of Singapore Business School. His career began with five years as an orthopedic surgeon at a top-tier hospital in Shanghai.
Transitioning to the med-tech industry in 2009, he built over 16 years of distinguished experience at leading global companies including Medtronic, TRUMPF Medical, Baxter, and Rejoin, holding regional and global leadership roles across Greater China, APAC, and worldwide. He has deep, long-term expertise in the OR equipment, orthopedic implants, and related high-value consumables sectors, with a proven track record in product management, market development, clinical education, and channel partnership.
Ms. Ada Xie
Vice President of Contact Manufacturing Business Unit
Ada joined Amsino in May 2002 as a Logistics Manager, and was promoted to Logistics Director in April 2008, and was then promoted again to Senior Director of Supply Chain in February 2012. Her responsibilities included Amsino Medical Group Logistics, Third Party Supplier Management, and Sales & Operation Planning. Ada was promoted to Vice President of Contract Manufacturing in 2019.
Ada received her Bachelor’s degree of Economics from Zhejiang GongShang University.
Prior to joining Amsino, Ada managed both Purchasing and Logistics for an American international tooling company.
Mr. Chester Chai
Sr. VP BD & Legal Affaires
Chester Chai returned to Amsino in 2018 as SVP of Global Marketing, Business Development and Assistant to the CEO. He comes to Amsino with over 28 years of medical device industry with experience working with companies such as Baxter, Hospira, and DeRoyal in both China and the United States. His extensive background includes business development, strategic planning, finance, marketing, supply chain management, product development, and venture capital investment.
Chester previously held the position of Corporate VP for Amsino from 2009 to 2012. He then moved to DeRoyal as the General Manager of Greater China and later established and managed a sourcing company, before returning to Amsino in 2018.
Chester has earned his M.B.A. degree from Kellogg School of Management at the University of Northwestern and an M.S. degree in Accounting from the University of Colorado Boulder. He has received his C.P.A. and also holds a B.S. degree in Mechanical Engineering from Shanghai Jiaotong University.
Mr. Paul Parisien
Senior VP R&D & Commercialization- Pharma Packaging
Coming soon.
Ms. Jane Gao
Senior VP of R&D and Commercialization--Medical Device
As Senior Vice President of R&D and Commercialization (Medical Devices), Jane leads the Medical Devices function and oversees the management, development and commercialization of product portfolios covering infusion therapy, enteral nutrition, urology and respiratory care.
Jane joined Amsino in April 2001 as a Product Manager. She was promoted to Project Development Department Manager since 2003 for all the new projects development. Jane was relocated to Amsino Medical (Shanghai) Co., Ltd as Deputy General Manager since November of 2005 until September of 2007. Jane was transferred to Amsino JD plant during September of 2007 to June of 2011 as General Manger.As of 2012, Jane has assumed the VP of R&D role. Promoted to Senior Vice President, R&D and Commercialization in February 2026.
Jane holds a Bachelor in Engineering from Jiangxi University of Science and Technology, with an emphasis in Mining Process Engineering.
Prior to joining Amsino, Jane worked for another Linhwa, a medical device company, for more than 4 years. She served as a product & mould technician, assistant to GM and international sales.
Mr. Danny Lu
VP of R&D and Commercialization – Digital Transformation
Danny heads the Digital Transformation function, responsible for the development and commercialization of the iRECEPTAL digital surgical aspiration system and future digital transformation systems.
In May 2022, Danny was appointed Director of the Amsino Group AI & Clinical Application Research Center. He was promoted to Vice President of R&D and Commercialization in February 2026.
Danny graduated from South China University of Technology in 2007, majoring in Information Engineering. He obtained a Patent Agent Qualification Certificate in 2011. He boasts over 15 years of intellectual property experience spanning law firm and in-house corporate roles, alongside three years of R&D experience on the iRECEPTAL 3 platform.
Mr. Paul Shen
Vice President of Quality Assurance
Paul Shen joined Amsino in 2001 as a Quality Manager, and was promoted to Vice President of QA in October, 2018. During his tenure at Amsino, Paul has served as Quality Manager, Deputy General Manager of Amsino Medical (Kunshan) Co., Ltd., Deputy General Manager of Amsino Medical (Shanghai) Co., Ltd, QC Director, and General Manager of Amsino Medical (Kunshan) Co., Ltd.
Paul received his Bachelor’s degree in microbiology from Fudan University, China.
Prior to joining Amsino, Paul Shen worked in Johnson & Johnson pharmaceutical company as a microbiologist and worked in Wyeth Nutritional company as a QA Supervisor.